Results 181 to 190 of about 9,997,733 (366)
Monoclonal antibodies in the diagnosis of lymphoproliferative diseases of the orbit and orbital adnexae [PDF]
A. J. Norton
openalex +1 more source
TBC1D22B, a Golgi‐localized RabGAP linked to poor prognosis in breast cancer, inhibits ER‐to‐Golgi transport via RAB1B inactivation. This disrupts secretion, drives oncogenic transcriptional reprogramming, and promotes tumor growth. These findings indicate that TBC1D22B connects membrane trafficking to transcriptional control and cancer progression ...
Flavia Martino +16 more
wiley +1 more source
Evaluating multiple large language models on orbital diseases. [PDF]
Yang QC +7 more
europepmc +1 more source
Mild phototherapy integrated chemotherapy (mild‐PIC) monitored by real‐time impedance spectroscopy enhances drug efficacy in liver cancer via the “More Light‐Aiding, Less Bonding (LALB)” mechanism, achieving higher targeting with lower toxicity. Abstract Phototherapy integrated chemotherapy (PIC) offers a promising cancer treatment strategy as single ...
Tongge Li +15 more
wiley +1 more source
Targeted immunotherapies for Graves' thyroidal & orbital diseases. [PDF]
Lee ACH, Kahaly GJ.
europepmc +1 more source
Dysthyroid Eye Disease with Radiological Features of Orbital Tumour
Fiona Lewis +3 more
openalex +1 more source
This study presents MF3Ec‐TBPP nanoparticles for targeted photodynamic therapy of Luminal A breast cancer. These nanoparticles combine an AIE‐based photosensitizer with an aptamer. Tests show they effectively inhibit tumor growth while protecting healthy tissue via aggregation and dipalmitoylphosphatidylcholine, indicating potential for improved ...
Charlie C. H. Ma +13 more
wiley +1 more source
Use of Robotic Surgery for the Management of Orbital Diseases: A Comprehensive Review. [PDF]
Nocini R +8 more
europepmc +1 more source

